IP Library Granted Patent US 10,925,892
Granted Patent B2
US 10,925,892 · App. 16/281,316 · Granted Feb 23, 2021

Lipid-based ophthalmic emulsion

Inventors: Howard Allen Ketelson (Dallas, TX); James W. Davis (Falmouth, ME); Rekha Rangarajan (Fort Worth, TX)
Assignee: Alcon Inc.
A61K31/736A61K9/0048A61K9/107A61K47/14A61K47/24A61P27/02B01F17/0028B01F17/0064B01F17/0085A61K47/02A61K47/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,925,892
App. No.
16/281,316
Granted
Feb 23, 2021
Kind
B2
Abstract

The present invention is directed to a lipid-based ophthalmic emulsion. The emulsion has an increased amount of a mucoadhesive galactomannan polymer that promotes a long-lasting protection against desiccation and moisture retention.

Claims (27)

1. An ophthalmic emulsion, the emulsion comprising:

water forming an aqueous phase;

oil forming an oil phase;

a hydrophilic surfactant having an HLB value from 10 to 18;

a hydrophobic surfactant having an HLB value from 1 to 6;

a charged phospholipid;

borate;

a mucoadhesive galactomannan polymer; and

a preservative;

wherein the mucoadhesive galactomannan polymer is present in the emulsion at a concentration of at least about 0.13 w/v % but no greater than 0.3 w/v %;

wherein the preservative is free of a benzalkonium chloride; and

wherein the ophthalmic emulsion has a hydration protection against desiccation of at least 10% higher than a control emulsion, wherein the control emulsion has the same composition of the ophthalmic emulsion except of containing 0.05 w/v % of the same galactomannan polymer used in the ophthalmic emulsion.

2. The emulsion as in claim 1 wherein the oil is a hydrocarbon selected from mineral oil, paraffin oil and petrolatum.

3. The emulsion as in claim 1 wherein the oil is at least 0.1 w/v % and no greater than 3 w/v % of the emulsion.

4. The emulsion as in claim 3 wherein the hydrophilic surfactant is present in the emulsion in an amount that is at least 0.08 w/v % and is no greater than about 0.8 w/v %.

5. The emulsion as in claim 4 wherein the hydrophilic surfactant is polyoxyethylene-40-stearate.

6. The emulsion as in claim 4 wherein the hydrophobic surfactant is at least about 0.01 w/v % and is no greater than 2.0 w/v %.

7. The emulsion as in claim 6 wherein the hydrophobic surfactant is a sorbitan tristearate.

8. The emulsion as in claim 1 wherein the mucoadhesive galactomannan polymer is selected from the group consisting of guar and hydroxypropyl guar.

9. The emulsion as in claim 8 wherein the charged phospholipid is an anionic phospholipid named dimyristoyl phosphatidylglycerol.

10. The emulsion as in claim 1 further comprising a borate/polyol buffer system.

11. The emulsion as in claim 10 wherein the preservative is a polymeric quaternary ammonium compound.

12. The emulsion as in claim 1 , wherein:

i. the oil phase is in droplets within the aqueous phase and the droplets have a D 90 diameter that is no greater than about 700 nm but is at least 10 nm; and

ii. the borate and galactomannan polymer cooperatively act to form a gel upon instillation of the emulsion in an eye of an individual.

13. The emulsion as in claim 12 , wherein the oil phase is in droplets within the aqueous phase and the droplets have a D 90 diameter that is no greater than about 500 nm but is at least 30 nm.

14. The emulsion as in claim 13 , wherein the oil phase is in droplets within the aqueous phase and the droplets have a D 90 diameter that is no greater than about 300 nm but is at least 50 nm.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2019
From: KETELSON, HOWARD ALLEN; RANGARAJAN, REKHA; DAVIS, JAMES W.
To: ALCON RESEARCH, LTD.
Reel/Frame 049985/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2019
From: ALCON RESEARCH, LTD.
To: NOVARTIS AG
Reel/Frame 049985/0659 →
Continuity (2)
Provisional Application 62633359 · Feb 21, 2018
Related Publication 20190255096A1 · Aug 22, 2019